Lead sponsor
Sun Pharmaceutical Industries Limited
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
2
Active
325
Total enrollment
24
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
1
Trials by status
Recruiting
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes MellitusBMI ≥27Ph 2Recruiting285
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal InsufficiencyBMI 18-42Ph 1Recruiting40